Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine
Published
Jul 22 2020 at 9:03 AM GMT
Key
Points
Points
- Audience: Consumer, Health Professional, Pharmacy July 22, 2020 -- Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0 9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.
Trending
Stats
- Published Jul 22, 2020 9:03 AM GMT